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Italy is the first European country in which the COVID-
19 epidemic outbreak has spread, starting from two re-
gions in Northern Italy, Veneto, and Lombardia. The
outbreak poses a relevant burden on hospital resources,
with a marked increase in the intensive care unit (ICU)
occupancy rates [1].
It has been hypothesized that the proportion of severe
infections that need intensive care could be affected by
the testing strategy. At the beginning of the epidemic
outbreak (21 February), an extensive testing strategy of
both symptomatic and asymptomatic subjects has been
adopted in Veneto and Lombardia. However, soon after
the starting of the outbreak (27 February), the Italian
Ministry of Health introduced restrictions in testing
asymptomatic/mild symptomatic subjects. Such a rec-
ommendation has been a topic of debate among Ital-
ian scientists and policymakers since it has been
suggested that also asymptomatic patients seem to
transmit the infection [2]. For this reason, different
strategies have been adopted at the regional level,
thanks to the local autonomy of the regional health
services. The Lombardia region adopted the recom-
mendation [1], while the Veneto region did not apply
the restrictions in testing asymptomatic/mild symp-
tomatic patients [3], in line with the strategy adopted
by the Republic of Korea.
To compare such two testing strategies, we assessed
the relationship between the percentage of ICU admis-
sions on the resident population and the percentage of
asymptomatic/mild symptomatic subjects tested on the
resident population, in Lombardia and Veneto.
Analyses are based on official data [4]. The asymptom-
atic/mild symptomatic subjects tested were obtained by
subtracting the daily number of newly hospitalized pa-
tients from the total number of tests performed on the
same day. The choice of asymptomatic patients instead
of the overall number of patients was performed to avoid
artifactual collinearity in the two dimensions being ana-
lyzed. Smoothing approximation using a loess regression
method using polynomials of degree 2 with the alpha
parameter set to 1.5 [5] has been fitted. The results are
reported in Fig. 1. At the beginning of the observation
(24 February), the percentage of asymptomatic/mild
symptomatic subjects tested was 0.014% in Lombardia
and 0.044% in Veneto, with 0.00019% and 0.00008% ad-
missions in ICU in Lombardia and Veneto, respect-
ively. At the 27th of March, the asymptomatic/mild
symptomatic subjects tested were 0.83% in Lombardia
and 1.66% in Veneto, with 0.01283% and 0.00689% of
subjects admitted to the ICU in Lombardia and Veneto,
respectively. Such data show a higher percentage of
asymptomatic/mild symptomatic subjects tested since
the beginning of the outbreak in Veneto, corresponding
to a lower percentage of subjects admitted to the ICU.
These findings suggest that testing also asymptomatic/
mild symptomatic patients would help reduce the pro-
portion of most severe cases eventually requiring ICU
and thus limiting the risk of saturation of ICU units.
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: dario.gregori@unipd.it
1Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac,
Thoracic, Vascular Sciences, and Public Health, University of Padova, Via
Loredan, 18, 35131 Padova, Italy
Full list of author information is available at the end of the article
Lorenzoni et al. Critical Care          (2020) 24:175 
https://doi.org/10.1186/s13054-020-02881-y
Acknowledgements
We gratefully acknowledge Giovanni Tripepi (National Research Council),
Maria Fusaro (University of Padova), Emanuele Cozzi (University of Padova),
and Federico Rea (University of Padova) for the helpful and fruitful
discussion.
COVID19ita Working Group
Dario Gregori (Project Coordinator), Corrado Lanera (App and R package
development), Paola Berchialla and Dolores Catelan (Epidemiological
Modeling), Danila Azzolina and Ilaria Prosepe (Predictive Models), Annibale
Biggeri, Cristina Canova, Elisa Gallo, and Francesco Garzotto (Enviromental
Epidemiology and Pollution Modeling), Giulia Lorenzoni and Nicolas Destro
(Risk Communication).
Authors’ contributions
DG, PB: substantial contributions to the conception and design of the work;
CL, DA data acquisition and analysis; GL, DG interpretation of data; GL
drafted the work. All authors have approved the submitted version (and any
substantially modified version that involves the author’s contribution to the
study). All authors have agreed both to be personally accountable for the
author’s own contributions and to ensure that questions related to the
accuracy or integrity of any part of the work, even ones in which the author
was not personally involved, are appropriately investigated, resolved, and the
resolution documented in the literature.
Funding
None
Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
NA
Consent for publication
NA
Competing interests
The authors declare that they have no competing interests.
Author details
1Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac,
Thoracic, Vascular Sciences, and Public Health, University of Padova, Via
Loredan, 18, 35131 Padova, Italy. 2Department of Translational Medicine,
University of Oriental Piedmont, Novara, Italy. 3Department of Clinical and
Biological Sciences, University of Turin, Novara, Italy.
Received: 1 April 2020 Accepted: 8 April 2020
References
1. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19
outbreak in Lombardy, Italy: early experience and forecast during an
emergency response. JAMA. 2020. [Epub ahead of print].
2. Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed asymptomatic
carrier transmission of COVID-19. JAMA. 2020. [Epub ahead of print].
3. Pisano GP, Sadun R, Zanini M. Lessons from Italy’s response to coronavirus.
Harvard Business Review. 2020 Mar 27; Available from: https://hbr.org/2020/
03/lessons-from-italys-response-to-coronavirus. [cited 2020 Mar 30].
4. {covid19ita}. covid19ita. Available from: https://r-ubesp.dctv.unipd.it/shiny/
covid19ita/. [cited 2020 Mar 28].
5. Harrell FE Jr. Regression modeling strategies with applications to linear
models, logistic and ordinal regression and survival analysis (2nd Edition).
Cham: Springer; 2015. http://biostat.mc.vanderbilt.edu/rms.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Fig. 1 The x-axis reports the percentage (%) of subjects not hospitalized who underwent COVID-19 testing; the x-axis reports the percentage (%)
of subjects admitted to the ICU (calculated on resident population). The continuous line indicates the local polynomial regression fitting; the
dotted line shows the observed percentages
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